“Bio-Rad Stock Plummets in Historic Selloff After 36 Years – S&P 500’s Biggest Decline Amid Dismal Results!”
Shares of Bio-Rad Laboratories Inc. experienced a significant 17.5% drop, marking their worst day in 36 years. This decline comes after the company reported first-quarter results that did not meet expectations, primarily due to a decrease in COVID-related sales. As a result, the life science research and clinical diagnostics product maker lowered its full-year outlook. […]